Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
raav2/5-hnaglu (1 trial)
Mucopolysaccharidosis III (Phase 2)
Syndrome (Phase 2)
Trials (1 total)
Trial APIs (1 total)